Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation
Journal of Cardiac Failure · 2024
DOI: 10.1016/j.cardfail.2023.09.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiac Failure, 2024. Verfasst von Keerthi T Gondi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Electronic address: keerthig@med.umich.edu. Hauptthemen laut MEDLINE: Heart Transplantation, Positron-Emission Tomography. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Positron emission tomography (PET) myocardial flow reserve (MFR) is a noninvasive method of detecting cardiac allograft vasculopathy in recipients of heart transplants (HTs). There are limited data on longitudinal change and predictors of MFR following HT. METHODS: We conducted a retrospective analysis of HT recipients undergoing PET myocardial perfusion imaging at an academic center. Multivariable linear and Cox regression models were constructed to identify longitudinal trends, predictors and the prognostic value of MFR after HT. RESULTS: Of HT recipients, 183 underwent 658 PET studies. The average MFR was 2.34 ± 0.70. MFR initially increased during the first 3 years following HT (+ 0.12 per year; P = 0.01) before beginning to decline at an annual rate of -0.06 per year (P < 0.001). MFR declines preceding acute rejection and improves after treatment. Treatment with mammalian target of rapamycin (mTOR) inhibitors (37.2%) slowed the rate of annual MFR decline (P = 0.03). Higher-intensity statin therapy was associated with improved MFR. Longer time post-transplant (P < 0.001), hypertension (P < 0.001), chronic kidney disease (P < 0.001), diabetes mellitus (P = 0.038), antibody-mediated rejection (P = 0.040), and cytomegalovirus infection (P = 0.034) were associated with reduced MFR. Reduced MFR (HR: 7.6, 95% CI: 4.4-13.4; P < 0.001) and PET-defined ischemia (HR: 2.3, 95% CI: 1.4-3.9; P < 0.001) were associated with a higher risk of the composite outcome of mortality, retransplantation, heart failure hospitalization, acute coronary syndrome, or revascularization. CONCLUSION: MFR declines after the third post-transplant year and is prognostic for cardiovascular events. Cardiometabolic risk-factor modification and treatment with higher-intensity statin therapy and mechanistic target of rapamycin inhibitors are associated with a higher MFR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Electronic address: keerthig@med.umich.edu.
- Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI.
- Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, MI.
Förderung
- NIH HHS
Zitieren
APA
Gondi, K. T., Hammer, Y., Yosef, M., Golbus, J. R., Madamanchi, C., Aaronson, K. D., Murthy, V. L., & Konerman, M. C. (2024). Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2023.09.013
Vancouver
Gondi KT, Hammer Y, Yosef M, Golbus JR, Madamanchi C, Aaronson KD, et al. Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation. Journal of Cardiac Failure. 2024. doi:10.1016/j.cardfail.2023.09.013
BibTeX
@article{Gondi2024,
author = {Gondi, Keerthi T and Hammer, Yoav and Yosef, Matheos and Golbus, Jessica R and Madamanchi, Chaitanya and Aaronson, Keith D and Murthy, Venkatesh L and Konerman, Matthew C},
title = {Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation},
journal = {Journal of Cardiac Failure},
year = {2024},
doi = {10.1016/j.cardfail.2023.09.013}
}
EUVIMED